Contraindications

EECP/ECP therapy should not be used for the treatment of patients with:

Mechanisms of Action

There is evidence demonstrating improved endothelial function via the hemodynamic effects by the increased shear stress acting on the arterial wall, reducing arterial stiffness and providing protective effects against inflammation, inhibiting intimal hyperplasia and the atherosclerotic process.

Suggested Treatment Protocol

ECP(EECP) milestone

EECP first received its FDA clearance as a Class III device in 1995 the indications for use were: Stable and unstable angina; Acute myocardial infarction; Cardiogenic shock

ECP(EECP) Principle

External Counterpulsation (ECP) is a non-surgical and non-pharmaceutical treatment for heart disease that is used to relieve or eliminate angina.